Latest Content

14 years after a rare lymphoma diagnosis, Edward Miskie answers real questions on survivorship, caregiving and life after cancer treatment.

After a kidney lesion proved unlikely to be cancer, a survivor embraces self-care, friendship and new opportunities with renewed gratitude and joy.

FDA approves Trodelvy alone or with Keytruda for the first-line treatment of adults with unresectable locally advanced or metastatic triple-negative breast cancer.

Susan Yaguda, oncology nurse at Atrium Health Levine Cancer Institute, transforms cancer care by treating the whole person — mind, body, and spirit — one patient at a time.

FDA approves Ibrance with trastuzumab and endocrine therapy for maintenance treatment of HR-positive, HER2-positive metastatic breast cancer.

A four-time cancer survivor shares how the Mariana Trench mirrors the journey through cancer, resilience, hope, and survival.

Nurse Navigator Nicola Stewart helped a Vietnamese-speaking patient with metastatic colon cancer overcome language, financial and care barriers.

FDA grants full approval to TECELRA and expands its use to eligible patients ages 12 and older with advanced synovial sarcoma after chemotherapy.

A cancer survivor shares what happens when a routine surveillance scan brings an unexpected finding — and how she navigated scanxiety, surgery, and an NED result.

Six years after remission, a survivor reflects on scan anxiety, recurrence fears, and the uncertainty of living with chronic cancer.

Oncology physical therapist Dr. Leslie Waltke, speaks with CURE , on identifying high-risk patients, overcoming the instinct to rest, and breaking down barriers to rehab access during cancer treatment.

“For nearly 11 years, my sister measured her cancer fight in holidays—wondering if she'd see spring again, or one more Christmas.”

Tammy Zinn, a finalist for the Extraordinary Healer Award, reflects on the personal loss that led her to oncology nursing and the programs she built to support patients.